相关实验视频
Updated: Sep 15, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
1.1K
在接受大量输血的严重重创伤患者中,输血比率和生存率
Toru Takiguchi1,2, Tomohisa Seki3, Takashi Tagami4,5
1Department of Emergency and Critical Care Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, Japan. toru-takiguchi@nms.ac.jp.
Scientific reports
|July 15, 2025
概括
对于严重创伤患者的最佳血液产品比率尚不清楚. 较高的新鲜冷血 (FFP) 与包装红细胞 (pRBC) 的比率,特别是1-1.5,改善了生存率. 特别是在带有冲击的骨干创伤中特别注意到这一点.
科学领域:
- 创伤外科 手术 创伤外科
- 血液性冲击管理 血液性冲击管理
- 输血医学 输血医学
背景情况:
- 大规模输血协议对于严重创伤患者至关重要.
- 血液制品 (红细胞,新鲜冷血,血小板) 的最佳比例尚未得到确立.
- 形创伤患者通常需要大量的血液制品.
研究的目的:
- 为了确定需要大量输血的严重重创伤患者的最佳输血比率.
- 调查新鲜冷血 (FFP) 与包装红细胞 (pRBC) 和血小板度 (PC) 与pRBC的比率和住院生存率之间的关联.
- 为了分析不同创伤表型中的这些比率.
主要方法:
- 使用日本创伤数据库 (2019-2022) 进行全国性的回顾性队列研究.
- 包括在24小时内接受≥10单位PRBC的患者.
- 分析的FP:pRBC和PC:pRBC比率 (0-0.5,0.5-1,1-1.5,1.5-2,>2) 和患者的表型.
主要成果:
- 1-1.5的FP:pRBC比率与显著更高的住院生存率 (aOR 1.46) 有关.
- 一个PC:pRBC比为1.5-2显示了改善生存率 (aOR 1.62) 的趋势.
- 在带有冲击的骨干创伤中,FFP:pRBC比率为1-1,5和>2改善了生存率.
结论:
- 较高的FFP:pRBC比率,特别是1-1.5,与严重的重创伤中改善的生存率有关.
- 更高的PC:pRBC比率也可能改善存活率.
- 这些发现特别适用于管理带有冲击的骨干创伤.
相关概念视频
Blood Transfusion and Agglutination
11.2K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.2K
Blood Transfusion
818
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
818
Bone Marrow Sampling and Transplants
502
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
502
Tissue Transplantation
524
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
524

